Stevanato Group Spa (NYSE:STVN) has a beta value of 0.58 and has seen 1.99 million shares traded in the last trading session. The company, currently valued at $6.14B, closed the last trade at $22.50 per share which meant it gained $3.12 on the day or 16.10% during that session. The STVN stock price is -54.36% off its 52-week high price of $34.73 and 26.4% above the 52-week low of $16.56. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.58 million shares traded. The 3-month trading volume is 482.66K shares.
The consensus among analysts is that Stevanato Group Spa (STVN) is Buy stock at the moment, with a recommendation rating of 1.55. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.14.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stevanato Group Spa (NYSE:STVN) trade information
Sporting 16.10% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the STVN stock price touched $22.50 or saw a rise of 1.1%. Year-to-date, Stevanato Group Spa shares have moved -17.55%, while the 5-day performance has seen it change 19.68%. Over the past 30 days, the shares of Stevanato Group Spa (NYSE:STVN) have changed 20.13%. Short interest in the company has seen 4.1 million shares shorted with days to cover at 7.76.
Wall Street analysts have a consensus price target for the stock at $25, which means that the shares’ value could jump 10.0% from current levels. The projected low price target is $19.0 while the price target rests at a high of $33.0. In that case, then, we find that the current price level is -46.67% off the targeted high while a plunge would see the stock lose 15.56% from current levels.
Stevanato Group Spa (STVN) estimates and forecasts
Figures show that Stevanato Group Spa shares have underperformed across the wider relevant industry. The company’s shares have lost -18.60% over the past 6 months, with this year growth rate of -20.63%, compared to 18.60% for the industry. Revenue growth from the last financial year stood is estimated to be 1.10%.
8 analysts offering their estimates for the company have set an average revenue estimate of 298.34M for the current quarter. 8 have an estimated revenue figure of 352.18M for the next ending quarter. Year-ago sales stood 296.18M and 347.75M respectively for this quarter and the next, and analysts expect sales will grow by 0.70% for the current quarter and 1.10% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 37.59% over the past 5 years. Earnings growth for 2024 is a modest -17.60% while over the next 5 years, the company’s earnings are expected to increase by 17.50%.
STVN Dividends
Stevanato Group Spa is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 0.06 at a share yield of 0.26%. The company’s dividend yield has gone up over the past 12 months.
Stevanato Group Spa (NYSE:STVN)’s Major holders
The top two institutional holders are CONESTOGA CAPITAL ADVISORS, LLC with over 7.28 million shares worth more than $133.44 million. As of 2024-06-30, CONESTOGA CAPITAL ADVISORS, LLC held 2.7358% of shares outstanding.
The other major institutional holder is NEUBERGER BERMAN GROUP LLC, with the holding of over 4.55 million shares as of 2024-06-30. The firm’s total holdings are worth over $83.46 million and represent 1.711% of shares outstanding.
